

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.32546756 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.32546756 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.10049583 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.10049583 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.96882497 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.66713259 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.66713259 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.66713259 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.44804092 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.38440308 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 5.30843050 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.30314397 |
| 13 | cysteine metabolic process (GO:0006534) | 5.22006659 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.20509315 |
| 15 | urea metabolic process (GO:0019627) | 5.06713208 |
| 16 | urea cycle (GO:0000050) | 5.06713208 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.04421391 |
| 18 | regulation of protein activation cascade (GO:2000257) | 5.03480423 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.02168046 |
| 20 | glycine metabolic process (GO:0006544) | 5.01732335 |
| 21 | negative T cell selection (GO:0043383) | 5.01367859 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.01342899 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.97571052 |
| 24 | DNA deamination (GO:0045006) | 4.87427983 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.86465642 |
| 26 | negative thymic T cell selection (GO:0045060) | 4.82463759 |
| 27 | regulation of complement activation (GO:0030449) | 4.73070331 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.70669435 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.67092074 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65642347 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.63292922 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.61171790 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.54187933 |
| 34 | bile acid metabolic process (GO:0008206) | 4.54059814 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.51429559 |
| 36 | protein carboxylation (GO:0018214) | 4.50070628 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.50070628 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.48849724 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.48411554 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.45811039 |
| 41 | activated T cell proliferation (GO:0050798) | 4.43339085 |
| 42 | serine family amino acid metabolic process (GO:0009069) | 4.42298307 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41907748 |
| 44 | serine family amino acid biosynthetic process (GO:0009070) | 4.29532663 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 4.28134001 |
| 46 | bile acid and bile salt transport (GO:0015721) | 4.27638283 |
| 47 | tolerance induction (GO:0002507) | 4.24141534 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.22887505 |
| 49 | positive T cell selection (GO:0043368) | 4.22499446 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.19628630 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19444486 |
| 52 | negative regulation of cell killing (GO:0031342) | 4.19444486 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11399600 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 4.08682742 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.06775947 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.06775947 |
| 57 | interferon-gamma production (GO:0032609) | 4.04986756 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.98499056 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.98499056 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.98499056 |
| 61 | response to interleukin-15 (GO:0070672) | 3.98118686 |
| 62 | amine catabolic process (GO:0009310) | 3.92246992 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 3.92246992 |
| 64 | lysine metabolic process (GO:0006553) | 3.90198907 |
| 65 | lysine catabolic process (GO:0006554) | 3.90198907 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.90192613 |
| 67 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89855805 |
| 68 | reverse cholesterol transport (GO:0043691) | 3.87664173 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 3.87246100 |
| 70 | positive thymic T cell selection (GO:0045059) | 3.86586466 |
| 71 | positive regulation of granulocyte differentiation (GO:0030854) | 3.85670709 |
| 72 | phospholipid efflux (GO:0033700) | 3.83874684 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.83855506 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 3.82785121 |
| 75 | L-fucose catabolic process (GO:0042355) | 3.77040059 |
| 76 | fucose catabolic process (GO:0019317) | 3.77040059 |
| 77 | L-fucose metabolic process (GO:0042354) | 3.77040059 |
| 78 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.71876701 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71410614 |
| 80 | coenzyme catabolic process (GO:0009109) | 3.69606642 |
| 81 | negative regulation of cholesterol transport (GO:0032375) | 3.68584125 |
| 82 | negative regulation of sterol transport (GO:0032372) | 3.68584125 |
| 83 | cytolysis (GO:0019835) | 3.68344765 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.59612462 |
| 85 | urate metabolic process (GO:0046415) | 3.58952723 |
| 86 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.58448737 |
| 87 | ethanol oxidation (GO:0006069) | 3.56597521 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53400337 |
| 89 | T cell selection (GO:0045058) | 3.52370415 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.50882294 |
| 91 | plasma lipoprotein particle clearance (GO:0034381) | 3.50543148 |
| 92 | valine metabolic process (GO:0006573) | 3.49823429 |
| 93 | cytidine deamination (GO:0009972) | 3.49395883 |
| 94 | cytidine metabolic process (GO:0046087) | 3.49395883 |
| 95 | cytidine catabolic process (GO:0006216) | 3.49395883 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48498235 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48498235 |
| 98 | NAD biosynthetic process (GO:0009435) | 3.47484986 |
| 99 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.47003113 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 3.46633819 |
| 101 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.45703523 |
| 102 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.45703523 |
| 103 | pantothenate metabolic process (GO:0015939) | 3.45149090 |
| 104 | complement activation, classical pathway (GO:0006958) | 3.43956302 |
| 105 | protein activation cascade (GO:0072376) | 3.43072286 |
| 106 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.42789761 |
| 107 | complement activation (GO:0006956) | 3.41940642 |
| 108 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.41331226 |
| 109 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.41331226 |
| 110 | arginine metabolic process (GO:0006525) | 3.41150019 |
| 111 | organic acid catabolic process (GO:0016054) | 3.39963443 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.39963443 |
| 113 | positive regulation of defense response to virus by host (GO:0002230) | 3.38740586 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 3.38245438 |
| 115 | positive regulation of mRNA catabolic process (GO:0061014) | 3.37951417 |
| 116 | heme transport (GO:0015886) | 3.33935076 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33833502 |
| 118 | cholesterol efflux (GO:0033344) | 3.33059522 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.32937650 |
| 120 | glutamate metabolic process (GO:0006536) | 3.32930043 |
| 121 | cellular glucuronidation (GO:0052695) | 3.32907552 |
| 122 | cellular ketone body metabolic process (GO:0046950) | 3.32425954 |
| 123 | S-adenosylmethionine metabolic process (GO:0046500) | 3.31847264 |
| 124 | fibrinolysis (GO:0042730) | 3.31298576 |
| 125 | regulation of B cell differentiation (GO:0045577) | 3.31071745 |
| 126 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.30313932 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.29931158 |
| 128 | thymic T cell selection (GO:0045061) | 3.28699497 |
| 129 | cholesterol homeostasis (GO:0042632) | 3.28564461 |
| 130 | L-serine metabolic process (GO:0006563) | 3.28160819 |
| 131 | alpha-beta T cell differentiation (GO:0046632) | 3.27603272 |
| 132 | mast cell activation (GO:0045576) | 3.26529374 |
| 133 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.25789648 |
| 134 | folic acid metabolic process (GO:0046655) | 3.23918616 |
| 135 | sterol homeostasis (GO:0055092) | 3.21836884 |
| 136 | 2-oxoglutarate metabolic process (GO:0006103) | 3.20345814 |
| 137 | cofactor catabolic process (GO:0051187) | 3.20222752 |
| 138 | mast cell activation involved in immune response (GO:0002279) | 3.16897476 |
| 139 | mast cell degranulation (GO:0043303) | 3.16897476 |
| 140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16067935 |
| 141 | carnitine metabolic process (GO:0009437) | 3.12879059 |
| 142 | sulfur amino acid metabolic process (GO:0000096) | 3.12299472 |
| 143 | fatty acid oxidation (GO:0019395) | 3.11214075 |
| 144 | pyridine-containing compound biosynthetic process (GO:0072525) | 3.10749437 |
| 145 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.09516764 |
| 146 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.09516764 |
| 147 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.08928319 |
| 148 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08020228 |
| 149 | T cell migration (GO:0072678) | 3.03763602 |
| 150 | alpha-beta T cell activation (GO:0046631) | 3.00330732 |
| 151 | leukocyte aggregation (GO:0070486) | 3.00216610 |
| 152 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.99633469 |
| 153 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91144194 |
| 154 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90742241 |
| 155 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.90633392 |
| 156 | Peyers patch development (GO:0048541) | 2.89512210 |
| 157 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.89512210 |
| 158 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88794918 |
| 159 | necroptotic process (GO:0070266) | 2.87712825 |
| 160 | protein K11-linked deubiquitination (GO:0035871) | 2.85120088 |
| 161 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.84286397 |
| 162 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.82348710 |
| 163 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.80778135 |
| 164 | behavioral response to nicotine (GO:0035095) | 2.80723119 |
| 165 | regulation of regulatory T cell differentiation (GO:0045589) | 2.80328387 |
| 166 | positive regulation of interleukin-17 production (GO:0032740) | 2.78779386 |
| 167 | regulation of mRNA catabolic process (GO:0061013) | 2.78031574 |
| 168 | regulation of granulocyte differentiation (GO:0030852) | 2.74195679 |
| 169 | T cell receptor signaling pathway (GO:0050852) | 2.73011877 |
| 170 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72015991 |
| 171 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.71498089 |
| 172 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.71342470 |
| 173 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.71342470 |
| 174 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.71342470 |
| 175 | T cell differentiation (GO:0030217) | 2.71014851 |
| 176 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.66633774 |
| 177 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.65214572 |
| 178 | B cell receptor signaling pathway (GO:0050853) | 2.64557682 |
| 179 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.64428952 |
| 180 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.63211843 |
| 181 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.62274711 |
| 182 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.61806355 |
| 183 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.60058069 |
| 184 | neural tube formation (GO:0001841) | 2.59919425 |
| 185 | growth hormone receptor signaling pathway (GO:0060396) | 2.58896796 |
| 186 | rRNA catabolic process (GO:0016075) | 2.58617212 |
| 187 | interkinetic nuclear migration (GO:0022027) | 2.57180006 |
| 188 | T cell homeostasis (GO:0043029) | 2.55429015 |
| 189 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54463175 |
| 190 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.53805734 |
| 191 | T-helper cell differentiation (GO:0042093) | 2.53805734 |
| 192 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.51443580 |
| 193 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.51443580 |
| 194 | necrotic cell death (GO:0070265) | 2.50600495 |
| 195 | regulation of cell killing (GO:0031341) | 2.50085781 |
| 196 | regulation of defense response to virus by host (GO:0050691) | 2.50062042 |
| 197 | negative regulation of adaptive immune response (GO:0002820) | 2.49062964 |
| 198 | programmed necrotic cell death (GO:0097300) | 2.49059290 |
| 199 | cell wall macromolecule catabolic process (GO:0016998) | 2.48989210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.90830624 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23489564 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.68290298 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.49465210 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60246665 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.46405827 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.91398224 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.83049674 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.77736908 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.65171544 |
| 11 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.07606831 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.00283947 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.46168518 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.44185009 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.24999427 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14832192 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14472071 |
| 18 | GATA3_26560356_Chip-Seq_TH2_Human | 2.02179072 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98687069 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.97902731 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.95318792 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.94727594 |
| 23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.92822300 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85829181 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84139203 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82729487 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79994084 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.73057141 |
| 29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70406896 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65679247 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58654143 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54733306 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52635040 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50584001 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49794549 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47550297 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46895945 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46050409 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45447526 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.43388745 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41950727 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39932309 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.37756559 |
| 44 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37108187 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36143236 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35913582 |
| 47 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.34905133 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34420657 |
| 49 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33881752 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33538428 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32937358 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32628580 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32613277 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32410720 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.29868097 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28679865 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28590343 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27717190 |
| 59 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25654758 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25434249 |
| 61 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.24827173 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23891204 |
| 63 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.23882123 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23803179 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23755750 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23430149 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23369790 |
| 68 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23163630 |
| 69 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22902187 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22787418 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21288729 |
| 72 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20505109 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20310868 |
| 74 | GATA3_26560356_Chip-Seq_TH1_Human | 1.19925351 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19553618 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19133529 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17950760 |
| 78 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16815392 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16418129 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13852457 |
| 81 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11398660 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10701606 |
| 83 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10439778 |
| 84 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10407880 |
| 85 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10344538 |
| 86 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09871650 |
| 87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09557404 |
| 88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08123770 |
| 89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07964597 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07964597 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06609957 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06301534 |
| 93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06086602 |
| 94 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06043096 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06012017 |
| 96 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05793565 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05788101 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05621999 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05436312 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04414256 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03871851 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03629948 |
| 103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03406158 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03140177 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03136258 |
| 106 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.02123404 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01954283 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01694138 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01659165 |
| 110 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01107102 |
| 111 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00653300 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00632189 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00583488 |
| 114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00071425 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00071425 |
| 116 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00049832 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98333594 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97326313 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97326313 |
| 120 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97303109 |
| 121 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96622372 |
| 122 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96588873 |
| 123 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.96235779 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95860769 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95860769 |
| 126 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.95476159 |
| 127 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95315550 |
| 128 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95312991 |
| 129 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94354007 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94161094 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93847572 |
| 132 | * MYB_26560356_Chip-Seq_TH1_Human | 0.90958372 |
| 133 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89942042 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89853191 |
| 135 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.86604906 |
| 136 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.84852407 |
| 137 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.84147689 |
| 138 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83136228 |
| 139 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.83073913 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80560247 |
| 141 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80413407 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79641683 |
| 143 | MYC_22102868_ChIP-Seq_BL_Human | 0.79468051 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78355649 |
| 145 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.78053991 |
| 146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.78052777 |
| 147 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77164317 |
| 148 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.76341786 |
| 149 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76200074 |
| 150 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.75964207 |
| 151 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75124504 |
| 152 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.74890926 |
| 153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.73590696 |
| 154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73363742 |
| 155 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.73330440 |
| 156 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.72944325 |
| 157 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.71615584 |
| 158 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71403541 |
| 159 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71066072 |
| 160 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.70799551 |
| 161 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.69353379 |
| 162 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.69200136 |
| 163 | * MYB_26560356_Chip-Seq_TH2_Human | 0.67899481 |
| 164 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.67599068 |
| 165 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66898207 |
| 166 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66640408 |
| 167 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.66427166 |
| 168 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.66417628 |
| 169 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.66404690 |
| 170 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.66107140 |
| 171 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.65741894 |
| 172 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.65728976 |
| 173 | MAF_26560356_Chip-Seq_TH1_Human | 0.65710438 |
| 174 | MAF_26560356_Chip-Seq_TH2_Human | 0.62429447 |
| 175 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62384180 |
| 176 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.62262295 |
| 177 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62252339 |
| 178 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.61885973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.94527476 |
| 2 | MP0005360_urolithiasis | 6.25323773 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.71398799 |
| 4 | MP0005365_abnormal_bile_salt | 5.69986608 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.12430416 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05997065 |
| 7 | MP0003252_abnormal_bile_duct | 3.27976858 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.10014441 |
| 9 | MP0009840_abnormal_foam_cell | 3.07722928 |
| 10 | MP0005083_abnormal_biliary_tract | 2.43830699 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.32945195 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.31917102 |
| 13 | MP0005332_abnormal_amino_acid | 2.28464040 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.23009331 |
| 15 | MP0000609_abnormal_liver_physiology | 2.21436896 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.13170329 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.08666783 |
| 18 | MP0005387_immune_system_phenotype | 2.00791521 |
| 19 | MP0001790_abnormal_immune_system | 2.00791521 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.99227395 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.98126453 |
| 22 | MP0003868_abnormal_feces_composition | 1.91603004 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.88630674 |
| 24 | MP0001764_abnormal_homeostasis | 1.87253937 |
| 25 | MP0003195_calcinosis | 1.82526367 |
| 26 | MP0003646_muscle_fatigue | 1.80471851 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.80349278 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.79225097 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.78394776 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.69912158 |
| 31 | MP0003787_abnormal_imprinting | 1.69529900 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.69116951 |
| 33 | MP0003724_increased_susceptibility_to | 1.68591417 |
| 34 | MP0002009_preneoplasia | 1.68475396 |
| 35 | MP0008057_abnormal_DNA_replication | 1.64315426 |
| 36 | MP0002405_respiratory_system_inflammati | 1.64266715 |
| 37 | MP0003186_abnormal_redox_activity | 1.55031083 |
| 38 | MP0005451_abnormal_body_composition | 1.54937632 |
| 39 | MP0009697_abnormal_copulation | 1.48948224 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.46413630 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.44551017 |
| 42 | MP0003866_abnormal_defecation | 1.42193424 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.37751937 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34308112 |
| 45 | MP0008872_abnormal_physiological_respon | 1.33060391 |
| 46 | MP0000598_abnormal_liver_morphology | 1.31622057 |
| 47 | MP0005310_abnormal_salivary_gland | 1.31443369 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.28383728 |
| 49 | MP0003718_maternal_effect | 1.28123614 |
| 50 | MP0008995_early_reproductive_senescence | 1.26720997 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.21746314 |
| 52 | MP0002933_joint_inflammation | 1.20032401 |
| 53 | MP0002163_abnormal_gland_morphology | 1.19753679 |
| 54 | MP0005647_abnormal_sex_gland | 1.18488927 |
| 55 | MP0008469_abnormal_protein_level | 1.18339831 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.16721817 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.15037550 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.14883359 |
| 59 | MP0009763_increased_sensitivity_to | 1.14032467 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.12587126 |
| 61 | MP0009764_decreased_sensitivity_to | 1.10326408 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.08491334 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.08276556 |
| 64 | MP0001851_eye_inflammation | 1.06941046 |
| 65 | MP0004142_abnormal_muscle_tone | 1.05362505 |
| 66 | MP0002693_abnormal_pancreas_physiology | 1.03573180 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.01115817 |
| 68 | MP0002102_abnormal_ear_morphology | 1.01036136 |
| 69 | MP0005671_abnormal_response_to | 1.01004534 |
| 70 | MP0003011_delayed_dark_adaptation | 1.00687716 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.99179781 |
| 72 | MP0009785_altered_susceptibility_to | 0.97818608 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.95707613 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.95639509 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.95190826 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 0.93731696 |
| 77 | MP0004381_abnormal_hair_follicle | 0.93246929 |
| 78 | MP0003436_decreased_susceptibility_to | 0.92553564 |
| 79 | MP0001919_abnormal_reproductive_system | 0.92520144 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.92188812 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.92188812 |
| 82 | MP0001661_extended_life_span | 0.92042228 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.89665055 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.89470975 |
| 85 | MP0005408_hypopigmentation | 0.89371377 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.88536468 |
| 87 | MP0009278_abnormal_bone_marrow | 0.88481860 |
| 88 | MP0002132_abnormal_respiratory_system | 0.88455289 |
| 89 | MP0000685_abnormal_immune_system | 0.88293853 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.88138107 |
| 91 | MP0002006_tumorigenesis | 0.87009741 |
| 92 | MP0001853_heart_inflammation | 0.86932320 |
| 93 | MP0004947_skin_inflammation | 0.84718945 |
| 94 | MP0001968_abnormal_touch/_nociception | 0.84082377 |
| 95 | MP0001800_abnormal_humoral_immune | 0.81081302 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.80745680 |
| 97 | MP0004147_increased_porphyrin_level | 0.79740808 |
| 98 | MP0002234_abnormal_pharynx_morphology | 0.78433329 |
| 99 | MP0005025_abnormal_response_to | 0.78159099 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.76924272 |
| 101 | MP0005379_endocrine/exocrine_gland_phen | 0.76881152 |
| 102 | MP0004484_altered_response_of | 0.76392144 |
| 103 | MP0001663_abnormal_digestive_system | 0.75813183 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.75623897 |
| 105 | MP0005670_abnormal_white_adipose | 0.75465380 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.75297034 |
| 107 | MP0005448_abnormal_energy_balance | 0.75210778 |
| 108 | MP0005389_reproductive_system_phenotype | 0.74539284 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.74515364 |
| 110 | MP0006082_CNS_inflammation | 0.73496523 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.71844526 |
| 112 | MP0004742_abnormal_vestibular_system | 0.71826225 |
| 113 | MP0010155_abnormal_intestine_physiology | 0.70995288 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.70660823 |
| 115 | MP0001835_abnormal_antigen_presentation | 0.70282214 |
| 116 | MP0004043_abnormal_pH_regulation | 0.68834160 |
| 117 | MP0005395_other_phenotype | 0.66968036 |
| 118 | MP0009115_abnormal_fat_cell | 0.66191462 |
| 119 | MP0009745_abnormal_behavioral_response | 0.65663184 |
| 120 | MP0005535_abnormal_body_temperature | 0.65142073 |
| 121 | MP0002723_abnormal_immune_serum | 0.64356938 |
| 122 | MP0002254_reproductive_system_inflammat | 0.64072569 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.63577695 |
| 124 | MP0006292_abnormal_olfactory_placode | 0.62894272 |
| 125 | MP0000470_abnormal_stomach_morphology | 0.62751660 |
| 126 | MP0002722_abnormal_immune_system | 0.62597324 |
| 127 | MP0005334_abnormal_fat_pad | 0.59922472 |
| 128 | MP0002971_abnormal_brown_adipose | 0.58826607 |
| 129 | MP0000604_amyloidosis | 0.58814785 |
| 130 | MP0005266_abnormal_metabolism | 0.58687264 |
| 131 | MP0002419_abnormal_innate_immunity | 0.58417201 |
| 132 | MP0002796_impaired_skin_barrier | 0.58342474 |
| 133 | MP0002398_abnormal_bone_marrow | 0.58209071 |
| 134 | MP0008873_increased_physiological_sensi | 0.56269484 |
| 135 | MP0009379_abnormal_foot_pigmentation | 0.55694752 |
| 136 | MP0001756_abnormal_urination | 0.55446671 |
| 137 | MP0001873_stomach_inflammation | 0.54532986 |
| 138 | MP0000716_abnormal_immune_system | 0.54514127 |
| 139 | MP0004957_abnormal_blastocyst_morpholog | 0.54225004 |
| 140 | MP0002429_abnormal_blood_cell | 0.53193617 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.52023476 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.51517945 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.50161013 |
| 144 | MP0002420_abnormal_adaptive_immunity | 0.48075239 |
| 145 | MP0002452_abnormal_antigen_presenting | 0.48034409 |
| 146 | MP0001819_abnormal_immune_cell | 0.47489320 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.47361642 |
| 148 | MP0002928_abnormal_bile_duct | 0.47277729 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.47059338 |
| 150 | MP0004130_abnormal_muscle_cell | 0.47048962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.72991865 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.31986902 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.14016037 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.89993626 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.86675583 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.86200026 |
| 7 | Xanthomatosis (HP:0000991) | 5.56688823 |
| 8 | Hyperglycinemia (HP:0002154) | 5.15920808 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.10002439 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.85354524 |
| 11 | Complement deficiency (HP:0004431) | 4.73391650 |
| 12 | Abnormality of T cell number (HP:0011839) | 4.54851772 |
| 13 | Stomatitis (HP:0010280) | 4.49756483 |
| 14 | Hyperglycinuria (HP:0003108) | 4.35999728 |
| 15 | Hyperammonemia (HP:0001987) | 4.28030764 |
| 16 | Joint hemorrhage (HP:0005261) | 4.26989595 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.25006468 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.25006468 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.24947925 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 4.12227724 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09243677 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 4.01872174 |
| 23 | Fat malabsorption (HP:0002630) | 3.97301475 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93435229 |
| 25 | Epidermoid cyst (HP:0200040) | 3.84834540 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84356617 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.83911111 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.77739743 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67492280 |
| 30 | T lymphocytopenia (HP:0005403) | 3.65858467 |
| 31 | Abnormality of T cells (HP:0002843) | 3.65151357 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.64559668 |
| 33 | Stomach cancer (HP:0012126) | 3.63986197 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62925244 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.60188662 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 3.55565227 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.47572167 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 3.45634675 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.43385349 |
| 40 | Abnormality of complement system (HP:0005339) | 3.42407297 |
| 41 | Ketosis (HP:0001946) | 3.41410839 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 3.38828621 |
| 43 | Eosinophilia (HP:0001880) | 3.38564314 |
| 44 | Increased IgM level (HP:0003496) | 3.35613318 |
| 45 | Myositis (HP:0100614) | 3.30976966 |
| 46 | Abnormality of eosinophils (HP:0001879) | 3.28952680 |
| 47 | Congenital stationary night blindness (HP:0007642) | 3.28556681 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24787224 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 3.20239812 |
| 50 | IgG deficiency (HP:0004315) | 3.19902791 |
| 51 | Recurrent fungal infections (HP:0002841) | 3.12560477 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.12199830 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 3.11555377 |
| 54 | Hypercholesterolemia (HP:0003124) | 3.10168760 |
| 55 | Spontaneous abortion (HP:0005268) | 3.08283049 |
| 56 | Hyperbilirubinemia (HP:0002904) | 3.08045031 |
| 57 | Steatorrhea (HP:0002570) | 3.05505267 |
| 58 | Pancreatic cysts (HP:0001737) | 3.02611088 |
| 59 | Optic neuritis (HP:0100653) | 3.00376080 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 3.00376080 |
| 61 | Acanthocytosis (HP:0001927) | 2.99176736 |
| 62 | Granulocytopenia (HP:0001913) | 2.98693122 |
| 63 | Hypochromic anemia (HP:0001931) | 2.88159863 |
| 64 | Encephalitis (HP:0002383) | 2.87887027 |
| 65 | Pustule (HP:0200039) | 2.83396315 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81016046 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.80851505 |
| 68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80851505 |
| 69 | Leukocytosis (HP:0001974) | 2.80571880 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78194682 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78194682 |
| 72 | Attenuation of retinal blood vessels (HP:0007843) | 2.78183700 |
| 73 | Myocardial infarction (HP:0001658) | 2.75659335 |
| 74 | Agammaglobulinemia (HP:0004432) | 2.72167814 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.70162876 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.64589750 |
| 77 | Orchitis (HP:0100796) | 2.61022746 |
| 78 | Gout (HP:0001997) | 2.59933265 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.58954107 |
| 80 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.57359561 |
| 81 | Lethargy (HP:0001254) | 2.56343247 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.55053192 |
| 83 | Genetic anticipation (HP:0003743) | 2.52804161 |
| 84 | Abnormality of midbrain morphology (HP:0002418) | 2.51638515 |
| 85 | Molar tooth sign on MRI (HP:0002419) | 2.51638515 |
| 86 | Gingival bleeding (HP:0000225) | 2.51324178 |
| 87 | Meningitis (HP:0001287) | 2.49153114 |
| 88 | Thrombophlebitis (HP:0004418) | 2.46177469 |
| 89 | Renal cortical cysts (HP:0000803) | 2.44858969 |
| 90 | Eczematoid dermatitis (HP:0000976) | 2.42973253 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 2.41334059 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.40061448 |
| 93 | Metabolic acidosis (HP:0001942) | 2.40052977 |
| 94 | Vasculitis (HP:0002633) | 2.39206456 |
| 95 | Birth length less than 3rd percentile (HP:0003561) | 2.36836257 |
| 96 | Decreased central vision (HP:0007663) | 2.36779602 |
| 97 | Thyroiditis (HP:0100646) | 2.36412819 |
| 98 | Abnormality of the renal cortex (HP:0011035) | 2.35346841 |
| 99 | Pancreatic fibrosis (HP:0100732) | 2.35291744 |
| 100 | Pancreatitis (HP:0001733) | 2.30183045 |
| 101 | Abolished electroretinogram (ERG) (HP:0000550) | 2.29094770 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27563321 |
| 103 | Spastic diplegia (HP:0001264) | 2.26229267 |
| 104 | Menorrhagia (HP:0000132) | 2.23947627 |
| 105 | Progressive inability to walk (HP:0002505) | 2.23804968 |
| 106 | Gaze-evoked nystagmus (HP:0000640) | 2.23552580 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.23251367 |
| 108 | Combined immunodeficiency (HP:0005387) | 2.22956988 |
| 109 | Generalized aminoaciduria (HP:0002909) | 2.22450369 |
| 110 | Brushfield spots (HP:0001088) | 2.19099042 |
| 111 | Epistaxis (HP:0000421) | 2.18649529 |
| 112 | Hyperventilation (HP:0002883) | 2.18083640 |
| 113 | Esophageal varix (HP:0002040) | 2.17717040 |
| 114 | Poikilocytosis (HP:0004447) | 2.13353550 |
| 115 | Irritability (HP:0000737) | 2.12141868 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 2.11814075 |
| 117 | Skin nodule (HP:0200036) | 2.11772159 |
| 118 | Alveolar cell carcinoma (HP:0006519) | 2.10785441 |
| 119 | True hermaphroditism (HP:0010459) | 2.10320045 |
| 120 | Clumsiness (HP:0002312) | 2.09509350 |
| 121 | Recurrent bacterial skin infections (HP:0005406) | 2.08490383 |
| 122 | Pulmonary infiltrates (HP:0002113) | 2.08424189 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07667484 |
| 124 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07249155 |
| 125 | Chronic diarrhea (HP:0002028) | 2.06409592 |
| 126 | Abnormality of the prostate (HP:0008775) | 2.05541945 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 2.04826530 |
| 128 | Hemoptysis (HP:0002105) | 2.04444854 |
| 129 | Ketoacidosis (HP:0001993) | 2.04028930 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 2.03402390 |
| 131 | Hypoproteinemia (HP:0003075) | 2.02206607 |
| 132 | Type II lissencephaly (HP:0007260) | 2.01947801 |
| 133 | Keratoconjunctivitis sicca (HP:0001097) | 2.01937445 |
| 134 | Pulmonary embolism (HP:0002204) | 2.01739985 |
| 135 | Hypoplasia of the thymus (HP:0000778) | 2.01711526 |
| 136 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.01320575 |
| 137 | Malnutrition (HP:0004395) | 2.00915651 |
| 138 | Neutropenia (HP:0001875) | 2.00632796 |
| 139 | Progressive cerebellar ataxia (HP:0002073) | 2.00272237 |
| 140 | Nausea (HP:0002018) | 1.99886157 |
| 141 | Nephronophthisis (HP:0000090) | 1.99551647 |
| 142 | Neonatal onset (HP:0003623) | 1.99183481 |
| 143 | Recurrent skin infections (HP:0001581) | 1.98592217 |
| 144 | Recurrent abscess formation (HP:0002722) | 1.98232064 |
| 145 | Constricted visual fields (HP:0001133) | 1.97399906 |
| 146 | Joint swelling (HP:0001386) | 1.95763483 |
| 147 | Recurrent viral infections (HP:0004429) | 1.95429395 |
| 148 | Gastrointestinal infarctions (HP:0005244) | 1.94973502 |
| 149 | Decreased circulating renin level (HP:0003351) | 1.94529110 |
| 150 | Inability to walk (HP:0002540) | 1.94321767 |
| 151 | Mediastinal lymphadenopathy (HP:0100721) | 1.93901427 |
| 152 | Vascular calcification (HP:0004934) | 1.92824609 |
| 153 | Glomerulonephritis (HP:0000099) | 1.92694003 |
| 154 | Fair hair (HP:0002286) | 1.92442440 |
| 155 | Elevated hepatic transaminases (HP:0002910) | 1.91029400 |
| 156 | Increased serum ferritin (HP:0003281) | 1.89848390 |
| 157 | Verrucae (HP:0200043) | 1.89238118 |
| 158 | Papilloma (HP:0012740) | 1.89238118 |
| 159 | Cerebral edema (HP:0002181) | 1.88570075 |
| 160 | Chronic hepatic failure (HP:0100626) | 1.87871284 |
| 161 | B lymphocytopenia (HP:0010976) | 1.87853525 |
| 162 | Abnormal cartilage morphology (HP:0002763) | 1.86837784 |
| 163 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86826413 |
| 164 | Recurrent bronchitis (HP:0002837) | 1.86761860 |
| 165 | Neonatal hypoglycemia (HP:0001998) | 1.86494177 |
| 166 | Prolonged bleeding time (HP:0003010) | 1.86364614 |
| 167 | Abnormality of the renal medulla (HP:0100957) | 1.86019824 |
| 168 | Hypertriglyceridemia (HP:0002155) | 1.85152115 |
| 169 | Tetraplegia (HP:0002445) | 1.84706805 |
| 170 | Polycythemia (HP:0001901) | 1.82840525 |
| 171 | Large for gestational age (HP:0001520) | 1.79551147 |
| 172 | Prostate neoplasm (HP:0100787) | 1.78563455 |
| 173 | Protruding tongue (HP:0010808) | 1.78398577 |
| 174 | Increased mean platelet volume (HP:0011877) | 1.77899892 |
| 175 | Hypoglycemic seizures (HP:0002173) | 1.75768604 |
| 176 | Amyloidosis (HP:0011034) | 1.74870880 |
| 177 | Oral leukoplakia (HP:0002745) | 1.73951594 |
| 178 | Microcytic anemia (HP:0001935) | 1.71923338 |
| 179 | Abnormal platelet volume (HP:0011876) | 1.71698622 |
| 180 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.71038584 |
| 181 | Acute lymphatic leukemia (HP:0006721) | 1.70871577 |
| 182 | Abnormal gallbladder morphology (HP:0012437) | 1.70864053 |
| 183 | Vomiting (HP:0002013) | 1.69715322 |
| 184 | Hemorrhage of the eye (HP:0011885) | 1.69500402 |
| 185 | Anorexia (HP:0002039) | 1.67942853 |
| 186 | Conjunctival telangiectasia (HP:0000524) | 1.67601360 |
| 187 | Azoospermia (HP:0000027) | 1.67529515 |
| 188 | Hyperuricemia (HP:0002149) | 1.66860370 |
| 189 | Increased purine levels (HP:0004368) | 1.66860370 |
| 190 | Proximal tubulopathy (HP:0000114) | 1.66849829 |
| 191 | Chest pain (HP:0100749) | 1.65750793 |
| 192 | Abnormality of the columella (HP:0009929) | 1.65652619 |
| 193 | IgM deficiency (HP:0002850) | 1.65525270 |
| 194 | Hemiplegia (HP:0002301) | 1.65007149 |
| 195 | Widely spaced teeth (HP:0000687) | 1.64562391 |
| 196 | Generalized hypopigmentation of hair (HP:0011358) | 1.63238978 |
| 197 | Abnormality of the renal collecting system (HP:0004742) | 1.59624333 |
| 198 | Abnormal biliary tract physiology (HP:0012439) | 1.58518345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.58401561 |
| 2 | BCKDK | 4.38528507 |
| 3 | FGFR4 | 3.56725272 |
| 4 | TLK1 | 3.55934494 |
| 5 | TXK | 2.83463946 |
| 6 | KDR | 2.63045500 |
| 7 | MAP4K1 | 2.60573283 |
| 8 | TAOK3 | 2.54990805 |
| 9 | WEE1 | 2.31844017 |
| 10 | BUB1 | 2.30655499 |
| 11 | ERN1 | 2.27262648 |
| 12 | ADRBK2 | 2.16936119 |
| 13 | PIK3CA | 2.05485190 |
| 14 | FES | 2.04134172 |
| 15 | TYK2 | 2.02418128 |
| 16 | ACVR1B | 1.96856752 |
| 17 | STK16 | 1.88461798 |
| 18 | NME2 | 1.87426017 |
| 19 | EIF2AK1 | 1.85870212 |
| 20 | CAMKK2 | 1.81736417 |
| 21 | MAP4K2 | 1.81028086 |
| 22 | SIK1 | 1.80002947 |
| 23 | JAK3 | 1.73539259 |
| 24 | FLT3 | 1.67093874 |
| 25 | ZAK | 1.63601930 |
| 26 | CDK19 | 1.60110128 |
| 27 | TIE1 | 1.58013038 |
| 28 | BMPR1B | 1.54349696 |
| 29 | MAPK11 | 1.49650140 |
| 30 | ZAP70 | 1.48477342 |
| 31 | TEC | 1.45607447 |
| 32 | IRAK3 | 1.44446833 |
| 33 | TNK2 | 1.43648252 |
| 34 | MAP2K3 | 1.41125645 |
| 35 | EIF2AK3 | 1.40944665 |
| 36 | IKBKE | 1.38511255 |
| 37 | NEK2 | 1.38182215 |
| 38 | NEK9 | 1.37287239 |
| 39 | ITK | 1.35005915 |
| 40 | PINK1 | 1.32677711 |
| 41 | OXSR1 | 1.31859510 |
| 42 | BRSK2 | 1.30901944 |
| 43 | ERBB4 | 1.29967390 |
| 44 | TSSK6 | 1.27997223 |
| 45 | MARK3 | 1.25594757 |
| 46 | PLK4 | 1.25211356 |
| 47 | DYRK3 | 1.23073665 |
| 48 | TBK1 | 1.22628338 |
| 49 | RIPK4 | 1.20534600 |
| 50 | MAP3K14 | 1.13229288 |
| 51 | STK10 | 1.12474134 |
| 52 | SIK2 | 1.11752309 |
| 53 | PIK3CG | 1.09621886 |
| 54 | JAK1 | 1.08671665 |
| 55 | CDK4 | 1.08565782 |
| 56 | NLK | 1.08066522 |
| 57 | PKN2 | 1.07622901 |
| 58 | TGFBR2 | 1.06686982 |
| 59 | RPS6KA4 | 1.06060410 |
| 60 | PASK | 1.05353651 |
| 61 | JAK2 | 1.05194382 |
| 62 | PIM1 | 1.05185491 |
| 63 | NUAK1 | 1.04444868 |
| 64 | GRK6 | 1.03991286 |
| 65 | HCK | 1.02849402 |
| 66 | IRAK1 | 1.02462555 |
| 67 | PRKCQ | 1.01539066 |
| 68 | IRAK4 | 0.99066468 |
| 69 | BTK | 0.98549188 |
| 70 | ABL2 | 0.95279308 |
| 71 | MAPK4 | 0.92345395 |
| 72 | BLK | 0.91999609 |
| 73 | IKBKB | 0.89424695 |
| 74 | MAPK13 | 0.88865345 |
| 75 | AKT3 | 0.86334590 |
| 76 | ADRBK1 | 0.84814271 |
| 77 | TGFBR1 | 0.83892206 |
| 78 | TNIK | 0.83110814 |
| 79 | CAMKK1 | 0.81988714 |
| 80 | BMPR2 | 0.81917679 |
| 81 | WNK3 | 0.81064534 |
| 82 | STK38L | 0.81063878 |
| 83 | GRK7 | 0.80240744 |
| 84 | INSRR | 0.78865402 |
| 85 | EPHA3 | 0.78369967 |
| 86 | EIF2AK2 | 0.76392127 |
| 87 | MAP2K6 | 0.74059426 |
| 88 | SRPK1 | 0.72634846 |
| 89 | CDK6 | 0.70551710 |
| 90 | TRPM7 | 0.70317533 |
| 91 | SIK3 | 0.69714519 |
| 92 | WNK4 | 0.68506774 |
| 93 | PDK4 | 0.67809735 |
| 94 | PDK3 | 0.67809735 |
| 95 | FGFR3 | 0.67799207 |
| 96 | CSNK1G1 | 0.66428440 |
| 97 | MAP3K4 | 0.65959310 |
| 98 | MST4 | 0.65881847 |
| 99 | EPHA2 | 0.65743532 |
| 100 | STK3 | 0.65736299 |
| 101 | STK11 | 0.64769571 |
| 102 | RAF1 | 0.63828440 |
| 103 | MAP2K4 | 0.62745081 |
| 104 | MAP3K3 | 0.61743390 |
| 105 | DAPK2 | 0.61359313 |
| 106 | KIT | 0.60894964 |
| 107 | CAMK1D | 0.58680844 |
| 108 | RPS6KB2 | 0.57116849 |
| 109 | PRKAA2 | 0.56004754 |
| 110 | PLK1 | 0.54684513 |
| 111 | MAP3K7 | 0.53829566 |
| 112 | MUSK | 0.53648551 |
| 113 | CSK | 0.53571489 |
| 114 | CDK7 | 0.52789390 |
| 115 | CSF1R | 0.52641317 |
| 116 | AURKB | 0.51004936 |
| 117 | GRK5 | 0.50182603 |
| 118 | TESK2 | 0.49804623 |
| 119 | MAP3K8 | 0.49348222 |
| 120 | LCK | 0.49300236 |
| 121 | MAP3K13 | 0.49281793 |
| 122 | MAP3K11 | 0.49023886 |
| 123 | PDK1 | 0.48523896 |
| 124 | MST1R | 0.48284495 |
| 125 | IGF1R | 0.47403930 |
| 126 | CAMK4 | 0.47033886 |
| 127 | HIPK2 | 0.46886810 |
| 128 | GRK1 | 0.46186937 |
| 129 | CHUK | 0.44983738 |
| 130 | MAP2K2 | 0.44970277 |
| 131 | MAPKAPK3 | 0.44425909 |
| 132 | PIM2 | 0.44002753 |
| 133 | CSNK1G3 | 0.43614708 |
| 134 | MATK | 0.43120753 |
| 135 | MKNK2 | 0.43089045 |
| 136 | PTK2B | 0.41673928 |
| 137 | BRSK1 | 0.40330446 |
| 138 | PDK2 | 0.39964048 |
| 139 | SYK | 0.39731099 |
| 140 | VRK1 | 0.37850047 |
| 141 | LATS1 | 0.37753961 |
| 142 | TTK | 0.37607380 |
| 143 | LYN | 0.37478485 |
| 144 | PRKAA1 | 0.36531364 |
| 145 | EPHB1 | 0.35996136 |
| 146 | MAPK12 | 0.35991113 |
| 147 | MAPK7 | 0.35164670 |
| 148 | MAPK15 | 0.34199197 |
| 149 | STK39 | 0.33297762 |
| 150 | CAMK1 | 0.32110501 |
| 151 | SGK2 | 0.30251496 |
| 152 | PAK3 | 0.28759686 |
| 153 | ABL1 | 0.28440336 |
| 154 | FGFR2 | 0.26332200 |
| 155 | RPS6KA6 | 0.26186519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39998182 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41323822 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17725711 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.14064802 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.02470570 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01136077 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.69381629 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67900291 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67651109 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.64104263 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62699145 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43068679 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39690745 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34815848 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.26959954 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.20612478 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.20183807 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17722036 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.16057821 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.15219901 |
| 21 | Asthma_Homo sapiens_hsa05310 | 2.15144557 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11755210 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.10860799 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05879447 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 2.01214567 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.88567498 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78871549 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78250624 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.77869902 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76030066 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75033970 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73844547 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73655376 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73229947 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70820845 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69139113 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66516068 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65787299 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.62483952 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62021089 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59649894 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58799058 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.55363459 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50786912 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49924649 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42248661 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41171883 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.38376730 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32361362 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29261214 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28855333 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.28812905 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27564045 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26733615 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25090988 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23282249 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22612367 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.18499397 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18100472 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17998414 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17476952 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17281782 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17101640 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15370407 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14408488 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13571520 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12845338 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 1.12485576 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10978340 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10194605 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09176791 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08985975 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03048420 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01542274 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00291912 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00182357 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97221942 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97039388 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.89606275 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89292157 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88203588 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.88168556 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87200487 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85786297 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83943361 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83122369 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81711847 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80276039 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79786456 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78829589 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76308453 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75643524 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.74590565 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73040094 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72667393 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.72117352 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71622687 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70454947 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67736003 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.66729169 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65676635 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63375305 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62783937 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61929447 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61323772 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61265518 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.58139711 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57619623 |
| 109 | Taste transduction_Homo sapiens_hsa04742 | 0.55950396 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53680309 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53081303 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.51551335 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50757672 |
| 114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.49344537 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46902922 |
| 116 | RNA polymerase_Homo sapiens_hsa03020 | 0.45704955 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45530238 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.45220380 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43886686 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43831293 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43278368 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42973404 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.42734725 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41704796 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41670833 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40014382 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39556285 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38765924 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38422019 |
| 130 | Proteasome_Homo sapiens_hsa03050 | 0.37855570 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37693978 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37624563 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36790990 |
| 134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36146391 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35854446 |
| 136 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35672742 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.34062722 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33813678 |
| 139 | DNA replication_Homo sapiens_hsa03030 | 0.33550069 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33419188 |
| 141 | Apoptosis_Homo sapiens_hsa04210 | 0.31854490 |
| 142 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28991285 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.28854566 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28568946 |
| 145 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.26047351 |
| 146 | Ribosome_Homo sapiens_hsa03010 | 0.24870538 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24479669 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23818350 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19630688 |
| 150 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.19205391 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.18395923 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.16391882 |
| 153 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.13409885 |
| 154 | Purine metabolism_Homo sapiens_hsa00230 | 0.12797241 |
| 155 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.10668439 |
| 156 | Measles_Homo sapiens_hsa05162 | 0.10548643 |
| 157 | Mismatch repair_Homo sapiens_hsa03430 | 0.07002967 |
| 158 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.06381492 |
| 159 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.06077923 |
| 160 | RNA transport_Homo sapiens_hsa03013 | 0.05030289 |
| 161 | Homologous recombination_Homo sapiens_hsa03440 | 0.04993818 |
| 162 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.03371733 |
| 163 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.03152049 |
| 164 | Basal transcription factors_Homo sapiens_hsa03022 | 0.01244114 |

